Neuroscience

Common treatment for multiple sclerosis may prolong life

Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.

Neuroscience

French firm announces multiple sclerosis drug breakthrough

French biotechnology company MedDay on Friday announced encouraging results for a multiple sclerosis (MS) drug trial, saying it decreased its progress and in some cases led to a "significant improvement" for sufferers.

Medical research

Multiple sclerosis drug works in a surprising way

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce ...

Neuroscience

Study: MS drugs help, but come at high cost

A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms ...

Neuroscience

Taking the reins on multiple sclerosis

Multiple sclerosis doesn't have to be an ending. With proper treatment and management, patients can manage the disease's often unpredictable nature.

Neuroscience

Drug may delay MS disability for some

An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary progressive MS, a new study finds.

Neuroscience

Antidepressant may help combat the course of multiple sclerosis

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remissions. As yet, drugs for this type of MS have been ...

page 1 from 3